International charity organization Oxfam has accused AstraZeneca of breaking its promises after the pharmaceutical company said it plans to start making a profit from its COVID-19 vaccine despite having previously pledged to sell at a very modest price.
The Pastu Covac vaccine has shown a 62 percent efficiency on new variants of coronavirus first emerged in South Africa and Brazil, 6 times more effective than the AstraZeneca vaccine, Health Minister Saeed Namaki announced on Monday.
Pharma giant AstraZeneca and Oxford University said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators.
AstraZeneca said on Tuesday it had begun testing an antibody-based treatment for the prevention and treatment of COVID-19.
AstraZeneca has said it has the capacity to manufacture one billion doses of the University of Oxford's potential COVID-19 vaccine and plans to begin supplying it in September.